Literature DB >> 1248486

Comparative HGH response to i.v. glucagon and i.v. arginine stimulation tests in children and adolescents.

Z Josefsberg, A Pertzelan, S Klonitzki-Peleg, R Kauli, A Silbergeld-Kowadlo, Z Laron.   

Abstract

Thirty-seven children and adolescents of several diagnostic entitites (constitutional growth retardation, diabetes mellitus and pituitary insufficiency) were tested with an i.v. bolus injection of glucagon for plasma human growth hormone (HGH) response. Most of the subjects were also tested for the same purpose by the arginine stimulation test, and the data were compared. It was found that i.v. glucagon is a potent stimulus of human growth hormone release. The HGH is released in two peaks, the first one occuring within 30 min, most probably by a direct effect. The second peak occurs after 120 min, most probably as a secondary effect caused by the drop in blood glucose after its initial rise, which is induced by glucagon. The peak concentrations of HGH induced by glucagon, were very similar to those provoked by i.v. arginine in the same subjects.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1248486     DOI: 10.1007/bf00443069

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

1.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

2.  Effect of intravenous glucagon on circulating levels of growth hormone and 17-hydroxycorticosteroids.

Authors:  E Danforth; P S Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  1970-01       Impact factor: 5.958

3.  Growth-hormone release by glucagon.

Authors:  M L Mitchell; M J Byrne; J Silver
Journal:  Lancet       Date:  1969-02-08       Impact factor: 79.321

4.  Assessment of growth hormone reserve: comparison of intravenous arginina and subcutaneous glucagon stimulation tests.

Authors:  S Podolsky; R Sivaprasad
Journal:  J Clin Endocrinol Metab       Date:  1972-10       Impact factor: 5.958

5.  Endogenous insulin and growth hormone response in children with newly diagnosed diabetes mellitus.

Authors:  A Drash; J B Field; L Y Garces; F M Kenny; D Mintz; A M Vazquez
Journal:  Pediatr Res       Date:  1968-03       Impact factor: 3.756

6.  Glucagon stimulation of human growth hormone.

Authors:  J P Cain; G H Williams; R G Dluhy
Journal:  J Clin Endocrinol Metab       Date:  1970-08       Impact factor: 5.958

7.  Plasma glucose, non-esterified fatty acid, insulin and growth hormone response to glucagon in the newborn.

Authors:  R D Milner; A D Wright
Journal:  Clin Sci       Date:  1967-04       Impact factor: 6.124

8.  Glucagon-initiated human growth hormone release: a comparative study.

Authors:  J P Cain; G H Williams; R G Dluhy
Journal:  Can Med Assoc J       Date:  1972-10-07       Impact factor: 8.262

9.  Growth hormone responses to propranolol-glucagon stimulation: a comparison with other tests of growth hormone reserve.

Authors:  J S Parks; J A Amrhein; V Vaidya; T Moshang; A M Bongiovanni
Journal:  J Clin Endocrinol Metab       Date:  1973-07       Impact factor: 5.958

10.  Hypoglycemia: a potent stimulus to secretion of growth hormone.

Authors:  J ROTH; S M GLICK; R S YALOW
Journal:  Science       Date:  1963-05-31       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.